[{"NetIncomeLoss_1_Q2_USD":158117000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-22581000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-36041000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":13388000.0,"PaymentsToAcquireInvestments_2_Q2_USD":7600000.0,"AccruedAdvertisingCurrentAndNoncurrent_0_Q2_USD":28505000.0,"Depreciation_1_Q2_USD":3393000.0,"Depreciation_2_Q2_USD":7844000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-2815163000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":294200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":517258000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-1018000.0,"InterestPaidNet_2_Q2_USD":32102000.0,"TreasuryStockCommonShares_0_Q2_shares":384366.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":114724000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":102726000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":478499000.0,"LiabilitiesNoncurrent_0_Q2_USD":3280970000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":354376000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":11030000.0,"AssetsCurrent_0_Q2_USD":2175380000.0,"OperatingLeaseExpense_2_Q2_USD":4000000.0,"OperatingLeaseExpense_1_Q2_USD":2400000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":45.06,"OperatingLeaseRightOfUseAsset_0_Q2_USD":85100000.0,"ShareBasedCompensation_2_Q2_USD":115590000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":235000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-873000.0,"Assets_0_Q2_USD":8207416000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":90840000.0,"CommonStockSharesIssued_0_Q2_shares":226099787.0,"IncomeTaxesPaidNet_2_Q2_USD":13435000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":68104000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":7356000.0,"GoodwillImpairedAccumulatedImpairmentLoss_0_Q2_USD":0.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":46500000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":200995000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":301363000.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":13177000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":355204000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":687196000.0,"LongTermDebtCurrent_0_Q2_USD":16000000.0,"LongTermDebt_0_Q2_USD":2576444000.0,"TreasuryStockValue_0_Q2_USD":4585000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":610559000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":21.67,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":7764000.0,"AccountsReceivableNetCurrent_0_Q2_USD":735433000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-262000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":2962000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-24641000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":235191860.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":234719830.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-6498000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":354891000.0,"RepaymentsOfLongTermLinesOfCredit_2_Q2_USD":4000000.0,"EarningsPerShareBasic_1_Q2_USD":0.7,"EarningsPerShareBasic_2_Q2_USD":0.15,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":1473915000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":148744000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":23.69,"ResearchAndDevelopmentExpense_1_Q2_USD":139834000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":197527000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q2_USD":30626000.0,"BusinessCombinationAcquisitionRelatedCosts_2_Q2_USD":80017000.0,"GoodwillPurchaseAccountingAdjustments_1_Q2_USD":7400000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-90235000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-42484000.0,"NumberOfReportableSegments_2_Q2_Segment":2.0,"CommonStockValue_0_Q2_USD":22000.0,"OperatingLeaseLiability_0_Q2_USD":108048000.0,"SeniorNotesCurrent_0_Q2_USD":16000000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":4260337000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":103500000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":812319000.0,"ProceedsFromLongTermLinesOfCredit_2_Q2_USD":1574993000.0,"OtherAssetsNoncurrent_0_Q2_USD":132595000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":88523000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":154892000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":880000000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":10306000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":33893000.0,"IncreaseDecreaseInInventories_2_Q2_USD":31713000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1468666000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-39000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-887000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":162736000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":11840000.0,"InterestPayableCurrent_0_Q2_USD":15688000.0,"StockIssuedDuringPeriodSharesAcquisitions_2_Q2_shares":1318053.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":158352000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"GoodwillGross_0_Q2_USD":1069000000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":40696000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":225119684.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":224523538.0,"GainLossOnDispositionOfAssets1_1_Q2_USD":2000000.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":2000000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":53112000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":85674000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":235000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-586000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":54424000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":141648000.0,"InterestIncomeExpenseNet_1_Q2_USD":-22581000.0,"InterestIncomeExpenseNet_2_Q2_USD":-36041000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":17.31,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":234.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":115633000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-55469000.0,"Goodwill_0_Q2_USD":1069031000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":33744000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":352951000.0,"LiabilitiesCurrent_0_Q2_USD":852810000.0,"AccountsPayableCurrent_0_Q2_USD":51947000.0,"NonoperatingIncomeExpense_2_Q2_USD":-33966000.0,"NonoperatingIncomeExpense_1_Q2_USD":-22882000.0,"NetIncomeLoss_2_Q2_USD":34766000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":220142000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":475154000.0,"InvestmentCompanyCommittedCapital_2_Q2_USD":48100000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":18180000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":549078000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":3119709000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":11482000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":993945.0,"PaymentsForProceedsFromLongtermInvestments_2_Q2_USD":7578000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":816158000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0488,"GrossProfit_1_Q2_USD":631553000.0,"GrossProfit_2_Q2_USD":873591000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":3999709000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":69896000.0,"LongTermDebtNoncurrent_0_Q2_USD":2560444000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":27839000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":365113000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":11482000.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":18115000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":350700000.0,"EarningsPerShareDiluted_1_Q2_USD":0.67,"EarningsPerShareDiluted_2_Q2_USD":0.15,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q2_USD":7996000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":54424000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":115590000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":108720000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":8207416000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":28.11,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":5473624000.0,"RestructuringAndRelatedCostIncurredCost_1_Q2_USD":930000.0,"RestructuringAndRelatedCostIncurredCost_2_Q2_USD":7023000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":58301.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2_Q2_USD":287000.0,"OperatingIncomeLoss_1_Q2_USD":138515000.0,"OperatingIncomeLoss_2_Q2_USD":-21503000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":832548000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1174954000.0,"CommonStockSharesAuthorized_0_Q2_shares":600000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":95123000.0,"DeferredFinanceCostsNet_0_Q2_USD":24405000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":2775330000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":11855000.0,"InventoryNet_0_Q2_USD":258676000.0,"GoodwillPurchaseAccountingAdjustments_2_Q2_USD":-7357000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":253886000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":179397000.0,"CommonStockSharesOutstanding_0_Q2_shares":225715421.0,"AssetImpairmentCharges_2_Q2_USD":12371000.0,"SeniorLongTermNotes_0_Q2_USD":2560444000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":68014000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-1267321000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-181120000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":6602752.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":7395188.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":2240000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":4600000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":2614026000.0,"AdvancesOnInventoryPurchases_0_Q2_USD":134716000.0,"StockholdersEquity_0_Q2_USD":4073636000.0,"GoodwillAcquiredDuringPeriod_2_Q2_USD":662719000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":171448000.0,"ProfitLoss_2_Q2_USD":34766000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":3839000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":62156000.0,"OperatingExpenses_1_Q2_USD":493038000.0,"OperatingExpenses_2_Q2_USD":895094000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":32255000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":25310000.0,"Ticker":"HZNP","CIK":"1492426","name":"HORIZON THERAPEUTICS PUBLIC LTD CO","OfficialName":"Horizon Therapeutics Public Limited Company Ordinary Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"26299872538.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]